Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2301studies shown
Showing 709-720 of 2,301
Behavioral study icon
CompletedNCT05988619

iCBT With TMS in people with MDD

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralOver 18 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Depression
Drug study icon
CompletedNCT01106313

Insulin Resistance in people with Major Depression

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

In United States
Why is this study shown?

This study is directly about Depression.

Depression, BipolarityOtherFrom 20 Years to 65 Years
Countries
United States
Sponsor
Stanford University
Condition
Depression, Bipolarity
Device study icon
SuspendedNCT02506127

Intermittent Theta Burst Stimulation for MDD

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 22 Years to 65 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Depression
Behavioral study icon
CompletedNCT03096886

Novel Neural Circuit Biomarkers of Major Depression Response to CCBT

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 60 Years
Countries
United States
Sponsor
University of Pennsylvania
Condition
Depression
Other study type icon
CompletedNCT05065580

OMT as an Adjunctive Treatment in MDD

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

Remote / online
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Corewell Health South
Condition
Depression
Drug study icon
CompletedNCT06391593

PD, PK, and Safety of ALTO-203 in people with MDD

This study exists to learn from real-world information that can show how the medication ALTO-203 fits into care. Researchers are trying to understand whether the medication ALTO-203 can improve attention, thinking, or day-to-day functioning.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.From 25 Years to 64 Years
Countries
United States
Sponsor
Alto Neuroscience
Condition
Depression
Drug study icon
CompletedNCT05712187

Phase 2b Study of ALTO-100 in MDD

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 64 Years
Countries
United States
Sponsor
Alto Neuroscience
Condition
Depression
Drug study icon
TerminatedNCT06011577

Study of REL-1017 as Adjunctive Treatment for MDD

This study was terminated in the United States. It focuses on Depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Levomecor Inc.
Condition
Depression
Behavioral study icon
CompletedNCT03378570

rTMS for MDD: 5.5cm Rule vs. F3 Targeting

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 90 Years
Countries
United States
Sponsor
Nicholas Trapp
Condition
Depression
Drug study icon
CompletedNCT06126497

Study Evaluating Safety and Efficacy of Ropanicant in MDD Patients

This study exists to understand whether a digital app or remote support tool is both safe enough and useful enough to take further. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

Remote / online
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Suven Life Sciences Limited
Condition
Depression
Drug study icon
CompletedNCT04814355

The Effect of Celecoxib on Neuroinflammation in MDD

This study is looking at whether Celecoxib 400 mg can help people with depression or Neuroinflammation. Participants receive a study treatment and complete follow-up visits and assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Stony Brook University
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.